We're currently a leading institution in Arizona and the surrounding states of New Mexico and Nevada approved to offer unique cellular therapies like Chimeric Antigen Receptor T-cell (CAR-T) for relapsed or refractory Acute Lymphoblastic Leukemia to patients 0-25 years old.

Our program is one of the few in the nation currently approved to administer CAR-T therapy for relapsed or refractory Acute Lymphoblastic Leukemia. Because we work with other specialties and departments, we can easily share skill sets and knowledge, ensuring the broadest care experience. Our program closely works with the Ottosen Family Blood & Marrow Transplant Program, which began in 2003 and consistently has greater than 90% one-year survival rate for allogenic transplants and is one of the best in the nation.

Access to Support Services

Our providers have access to a full-service Pathology and Laboratory Services Division, including a Transfusion Medicine and Apheresis Program. From 24/7 support to committed quality care, everything is in place for us to focus on the well-being of our patients and their families.

Cellular Therapy at Phoenix Children's